Find More Contacts for GlycoMimetics
Protected Content
CBO
Executive Management
2 emails found 1 phone number found
View contacts for GlycoMimetics to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email webmaster@glycomimetics.com
  • Phone Number 2402431207

GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound

for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.

Lists Featuring This Company

Southern US Biotechnology Female Founded Companies
350 Number of Organizations â€¢ $5.6B Total Funding Amount â€¢ 698 Number of Investors
East Coast Therapeutics Female Founded Companies
643 Number of Organizations â€¢ $18.6B Total Funding Amount â€¢ 964 Number of Investors
Maryland Companies With Less Than $500M in Revenue (Top 10K)
9,881 Number of Organizations â€¢ $33.2B Total Funding Amount â€¢ 2,686 Number of Investors
Dartmouth College Alumni Founded Companies
1,112 Number of Organizations â€¢ $33.7B Total Funding Amount â€¢ 3,130 Number of Investors

Frequently Asked Questions

Where is GlycoMimetics's headquarters? GlycoMimetics is located in Gaithersburg, Maryland, United States.Who invested in GlycoMimetics? GlycoMimetics has 8 investors including Cowen Investment Management and Novartis Venture Fund.How much funding has GlycoMimetics raised to date? GlycoMimetics has raised .When was the last funding round for GlycoMimetics? GlycoMimetics closed its last funding round on Sep 28, 2017 from a Post-IPO Equity round.Who are GlycoMimetics's competitors? Alternatives and possible competitors to GlycoMimetics may include CytokineticsMilestone Pharmaceuticals, and Proteostasis Therapeutics.